The Cancer Prevention and Research Institute of Texas has awarded nearly $3.4 million to UT Health San Antonio to advance ...

HPV vaccination can prevent 90% of cervical and anal cancers and most other cancers caused by HPV.* “Having worked in the cervical cancer awareness, prevention and treatment space, as an ...

Vaccinating females against human papillomavirus (HPV) prior to the debut of sexual activity is an effective way to prevent cervical cancer, yet vaccine uptake in low- and middle-income countries ...

China’s first domestically developed nine-valent human papillomavirus (HPV) vaccine has been approved for marketing by the National Medical Products Administration, breaking the more than decade ...

One-month surveys were completed by 66 and 39 Colorado and California clinicians (92 and 87%, respectively); 90 and 77%, respectively, were routinely initiating vaccines at age 9 or 10 years.

The HPV vaccine, delivered in schools, is the frontline defence in shielding the body from HPV infection. HPV causes cervical cancer, genital, anal and oral cancers — as well as genital warts.

The Serum Institute of India has launched a nationwide campaign to raise awareness about HPV's role in causing various ...

The Cancer Prevention and Research Institute of Texas awarded the university more than $2.4 million to tailor treatments for ...

. The HPV vaccine is expected to prevent up to 90% of cervical cancers . There is great potential for HPV vaccination to lead to the elimination of cervical cancer as a public health problem. In ...

Duke University HIV vaccine research center ended by Trump administration after Dr. Barton Haynes’ grant was not extended, adding to RFK Jr. pullback on mRNA technology.

Harper DM et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: A randomised controlled trial. Lancet ...